Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNg-Secreting Lymphocytes and IL12-Producing Dendritic Cells
ContributorsPfirschke, Christina; Zilionis, Rapolas; Engblom, Camilla; Messemaker, Marius; Zou, Angela E.; Rickelt, Steffen; Gort-Freitas, Nicolas A.; Lin, Yunkang; Bill, Ruben; Siwicki, Marie; Gungabeesoon, Jeremy; Sprachman, Melissa M.; Marquard, Angela N.; Rodell, Christopher B.; Cuccarese, Michael F.; Quintana, Jeremy; Ahmed, Maaz S.; Kohler, Rainer H.; Savova, Virginia; Weissleder, Ralph; Klein, Allon M.; Pittet, Mikaël
Published inCancer immunology research, vol. 10, no. 1, p. 40-55
Publication date2022-01
Citation (ISO format)
PFIRSCHKE, Christina et al. Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNg-Secreting Lymphocytes and IL12-Producing Dendritic Cells. In: Cancer immunology research, 2022, vol. 10, n° 1, p. 40–55. doi: 10.1158/2326-6066.CIR-21-0326
Main files (2)
Article (Published version)
Article (Accepted version)
Secondary files (7)
Identifiers
- PID : unige:169025
- DOI : 10.1158/2326-6066.CIR-21-0326
- PMID : 34795032
Additional URL for this publicationhttps://aacrjournals.org/cancerimmunolres/article/10/1/40/674703/Macrophage-Targeted-Therapy-Unlocks-Antitumoral
Journal ISSN2326-6066